retatrutide triple agonist obesity phase 2 trial Retatrutide, a (GLP1, GIP, glucagon), just released results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished What Is Retatrutide? Complete Guide

Supports Digestive Balance and Nutrient Absorption: This carefully crafted oral liquid supplement features six probiotic strains combined with prebiotic inulin to nurture a balanced gut environment

and its nonarteritic because it does not involve harm to the arteries in the area

The Omada Insights Lab found that after one year, the Enhanced GLP-1 Care Track had higher persistence rates and weight loss compared to published real-world estimates.

It highlights emerging evidence, safety considerations, and equity challenges that position GLP-1 RAs as a promising public health strategy for this high-risk population.

Curious what youre seeing in your part of the food world